Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled Study
Clinical trial NCT05946902 · UNKNOWN
Trial details
- NCT number
- NCT05946902
- Sponsor
- Far Eastern Memorial Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-12
- Primary completion
- 2024-07-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.